Fresenius SE & Co. KGaA



Fresenius - the health care group

Fresenius is a global health care group with products and services for dialysis, the hospital and the medical care of patients at home.

The Fresenius Group consists of the following four business segments that are responsible for their own business operations worldwide: Fresenius Medical Care, Fresenius KabiFresenius Helios and Fresenius Vamed.

Latest news

Fresenius Medical Care successfully places senior notes

Fresenius Medical Care successfully placed U.S. dollar senior unsecured notes in the amount of $500 million due 2020 with a coupon of 4.125% and in the amount of $400 million due 2024 with a coupon of 4.75%.

Fresenius nominates Allianz CEO Michael Diekmann for Supervisory Board

The Supervisory Board of Fresenius SE & Co. KGaA will propose that the next Annual General Meeting elect Mr. Michael Diekmann to the Supervisory Board. The Supervisory Board believes that his immense expertise and experience qualify Mr. Diekmann for the position of Deputy Chairman, which is now vacant.

Fresenius Medical Care announces offering of senior notes

Fresenius Medical Care today announced its intention to sell U.S. dollar denominated senior unsecured notes in an aggregate amount of $900 million with maturities of 6 and 10 years.

Fresenius Medical Care expands further in care coordination with the acquisition of National Cardiovascular Partners

Fresenius Medical Care today announced the acquisition of National Cardiovascular Partners (NCP). NCP is the leading operator of endovascular, vascular and cardiovascular services in the comfort and convenience of the outpatient setting.

Initial conversion price of equity-neutral convertible bonds fixed

Fresenius Medical Care has determined the initial conversion price of its equity-neutral convertible bonds.